Hypoxia and Transforming Growth Factor β Cooperate to Induce Fibulin-5 Expression in Pancreatic Cancer
Authors:
Open Access
- 1 October 2016
- journal article
- cell biology
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 291 (42) , 22244-22252
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (T32 GM008203, R01 CA118240)
This publication has 52 references indexed in Scilit:
- Matricellular proteins: priming the tumour microenvironment for cancer development and metastasisBritish Journal of Cancer, 2013
- Fibulin-5 Is Up-regulated by Hypoxia in Endothelial Cells through a Hypoxia-inducible Factor-1 (HIF-1α)-dependent MechanismJournal of Biological Chemistry, 2011
- TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progressionTrends in Immunology, 2010
- Smac Mimetic Increases Chemotherapy Response and Improves Survival in Mice with Pancreatic CancerCancer Research, 2010
- Fibulin-2 and Fibulin-5 Cooperatively Function to Form the Internal Elastic Lamina and Protect From Vascular InjuryArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Fibulin-5, an integrin-binding matricellular protein: its function in development and diseaseJournal of Cell Communication and Signaling, 2009
- Fibulin-5 Suppresses Lung Cancer Invasion by Inhibiting Matrix Metalloproteinase-7 ExpressionCancer Research, 2009
- Fibulin-5 initiates epithelial-mesenchymal transition (EMT) and enhances EMT induced by TGF- in mammary epithelial cells via a MMP-dependent mechanismCarcinogenesis, 2008
- LY2109761, a novel transforming growth factor β receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasisMolecular Cancer Therapeutics, 2008
- Fibulin-5 binds human smooth-muscle cells through α5β1 and α4β1 integrins, but does not support receptor activationBiochemical Journal, 2007